UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033908
Receipt number R000038654
Scientific Title A study to evaluate the effect of test food on body fat-reducing.
Date of disclosure of the study information 2018/08/29
Last modified on 2020/03/06 16:19:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the effect of test food on body fat-reducing.

Acronym

A study to evaluate the effect of test food on body fat-reducing.

Scientific Title

A study to evaluate the effect of test food on body fat-reducing.

Scientific Title:Acronym

A study to evaluate the effect of test food on body fat-reducing.

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate effects of a test food on the reduction of body fat.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Body fat area determined by CT

Key secondary outcomes

Body weight, body mass index, waist circumference, body fat percentage


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Daily intakes of a test food for 12 weeks

Interventions/Control_2

Daily intakes of a placebo food for 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1.Subjects whose BMI values are over 25 but less than 30.

Key exclusion criteria

1.Individuals being patient or have a history of serious disease of liver, kidney, heart, internal organs and diabetes.
2.Individuals who cannot quit to intake of supplements and/or medicine which may affect the results of measurement.
3.Individuals who are allergic to the test foods
4.Individuals who are pregnant, lactation, and planning to be pregnant
5.Subjects who drink alcohol a lot (60 g and more of alcohol a day on average) and/or smoke a lot (20 and more cigarettes a day on average)
6.Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift
7.Individuals who are judged as ineligible to participate this trial by physician

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Ishikawa

Organization

Medical Corporation Shoureikan Sinsapporo Seiryo Hospital

Division name

Internal Medicine

Zip code

004-0004

Address

4-2-1-30 , Atsubetsuhigashi, Atsubetsu-ku, Sapporo, Hokkaido

TEL

011-898-2151

Email

Ishikawa_seiryo@yahoo.co.jp


Public contact

Name of contact person

1st name Isao
Middle name
Last name Takehara

Organization

Clinical Support Corporation Co., Ltd

Division name

PI-Food Service Division

Zip code

060-0061

Address

4-1 South 1 West 8, Chuo-ku, Sapporo, Hokkaido

TEL

011-223-3130

Homepage URL


Email

takehara@csc-smo.co.jp


Sponsor or person

Institute

Medical Corporation Shoureikan Sinsapporo Seiryo Hospital

Institute

Department

Personal name



Funding Source

Organization

Asahi Group Holdings, LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Hokubukai Utsukushigaoka Hospital institutional review board

Address

61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, Japan

Tel

001-882-0111

Email

matsuda@ughp-cpc.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 29 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.mdpi.com/2076-2607/8/2/304

Number of participants that the trial has enrolled

169

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 06 Month 28 Day

Date of IRB

2018 Year 06 Month 28 Day

Anticipated trial start date

2018 Year 08 Month 29 Day

Last follow-up date

2019 Year 04 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 27 Day

Last modified on

2020 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038654


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name